Correction to “Diagnostic Panel of Three Genetic Biomarkers Based on Artificial Neural Network for Patients With Idiopathic Generalized Epilepsy”

IF 2.7 3区医学 Q2 CLINICAL NEUROLOGY

Acta Neurologica Scandinavica Pub Date : 2026-01-31 DOI:10.1155/ane/9843676

{"title":"Correction to “Diagnostic Panel of Three Genetic Biomarkers Based on Artificial Neural Network for Patients With Idiopathic Generalized Epilepsy”","authors":"","doi":"10.1155/ane/9843676","DOIUrl":null,"url":null,"abstract":"A. Y. Tak, N. Tak, A. Bayrakoglu, et al., “Diagnostic Panel of Three Genetic Biomarkers Based on Artificial Neural Network for Patients With Idiopathic Generalized Epilepsy,” Acta Neurologica Scandinavica, 2024 (2024): 8853018, https://doi.org/10.1155/2024/8853018.In the article, Alisan Bayrakoglu, Seda Susgun, and Ceyhun Toruntay were mistakenly omitted from the author list. The updated author list and affiliations are shown below and have been corrected in the article.Ayşegül Yabacı Tak1, Nihat Tak2, Alisan Bayrakoglu3, Seda Susgun4, Ceyhun Toruntay5, Ferda Ilgen Uslu3, Emrah Yucesan61. Bezmialem Vakıf University, Faculty of Medicine, Department of Biostatistics and Medical Informatics, Istanbul, Türkiye2. Marmara University, Faculty of Science, Department of Statistics, Istanbul, Türkiye3. Bezmialem Vakıf University, Faculty of Medicine, Department of Neurology, Istanbul, Türkiye4. Bezmialem Vakıf University, Faculty of Medicine, Department of Medical Biology, Istanbul, Türkiye5. Istanbul Technical University, Faculty of Science and Letters, Department of Molecular Biology and Genetics, Istanbul, Türkiye6. Istanbul Cerrahpaşa University, Institute of Neurological Sciences, Department of Neurogenetics, Istanbul, TürkiyeThe author contributions are as follows:Conceptualization: A.Y.T. and E.Y. Methodology: A.Y.T. and E.Y. Data curation: A.Y.T., N.T., S.S., C.T., F.I.U., and A.B. Formal analysis: A.Y.T. and N.T. Writing—original draft: A.Y.T., E.Y., and N.T. Writing—review and editing: A.Y.T., E.Y., and N.T. Visualization: A.Y.T. Supervision: A.Y.T.We apologize for this error.","PeriodicalId":6939,"journal":{"name":"Acta Neurologica Scandinavica","volume":"2026 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2026-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/ane/9843676","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Neurologica Scandinavica","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/ane/9843676","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

A. Y. Tak, N. Tak, A. Bayrakoglu, et al., “Diagnostic Panel of Three Genetic Biomarkers Based on Artificial Neural Network for Patients With Idiopathic Generalized Epilepsy,” Acta Neurologica Scandinavica, 2024 (2024): 8853018, https://doi.org/10.1155/2024/8853018.

In the article, Alisan Bayrakoglu, Seda Susgun, and Ceyhun Toruntay were mistakenly omitted from the author list. The updated author list and affiliations are shown below and have been corrected in the article.

Ayşegül Yabacı Tak¹, Nihat Tak², Alisan Bayrakoglu³, Seda Susgun⁴, Ceyhun Toruntay⁵, Ferda Ilgen Uslu³, Emrah Yucesan⁶

1. Bezmialem Vakıf University, Faculty of Medicine, Department of Biostatistics and Medical Informatics, Istanbul, Türkiye

2. Marmara University, Faculty of Science, Department of Statistics, Istanbul, Türkiye

3. Bezmialem Vakıf University, Faculty of Medicine, Department of Neurology, Istanbul, Türkiye

4. Bezmialem Vakıf University, Faculty of Medicine, Department of Medical Biology, Istanbul, Türkiye

5. Istanbul Technical University, Faculty of Science and Letters, Department of Molecular Biology and Genetics, Istanbul, Türkiye

6. Istanbul Cerrahpaşa University, Institute of Neurological Sciences, Department of Neurogenetics, Istanbul, Türkiye

The author contributions are as follows:

Conceptualization: A.Y.T. and E.Y. Methodology: A.Y.T. and E.Y. Data curation: A.Y.T., N.T., S.S., C.T., F.I.U., and A.B. Formal analysis: A.Y.T. and N.T. Writing—original draft: A.Y.T., E.Y., and N.T. Writing—review and editing: A.Y.T., E.Y., and N.T. Visualization: A.Y.T. Supervision: A.Y.T.

We apologize for this error.

查看原文本刊更多论文

对“基于人工神经网络的三种遗传生物标志物诊断特发性全面性癫痫”的修正

A. Y. Tak， N. Tak， A. Bayrakoglu等，“基于人工神经网络的特发性广泛性癫痫患者的三种遗传生物标志物诊断小组”，斯堪的纳维亚神经学报，2024 (2024):8853018,https://doi.org/10.1155/2024/8853018.In文章中，Alisan Bayrakoglu， Seda Susgun和Ceyhun Toruntay被错误地从作者列表中省略。更新的作者名单和隶属关系如下所示，并已在文章中进行了更正。ay eg l yabacyi Tak1, Nihat Tak2, Alisan Bayrakoglu3, Seda Susgun4, Ceyhun Toruntay5, Ferda Ilgen Uslu3, Emrah Yucesan61。Bezmialem Vakıf大学医学院，生物统计和医学信息系，伊斯坦布尔，土耳其，rkiye2。马尔马拉大学理学院，统计学系，伊斯坦布尔，土耳其；Bezmialem Vakıf大学医学院神经内科，伊斯坦布尔，土耳其，rkiye4。Bezmialem Vakıf土耳其伊斯坦布尔大学医学系医学生物学系，土耳其伊斯坦布尔，rkiye5。伊斯坦布尔技术大学，科学与文学院，分子生物学与遗传学系，伊斯坦布尔，土耳其，土耳其；作者贡献如下：概念化：A.Y.T.和E.Y.方法论：A.Y.T.和E.Y.数据管理：A.Y.T.， N.T., s.s., c.t.， F.I.U和A.B.形式分析：A.Y.T.和N.T.写作-原稿：A.Y.T.， E.Y.和N.T.写作-审查和编辑：A.Y.T.， E.Y.和N.T.可视化：A.Y.T.监督：A.Y.T.我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Neurologica Scandinavica 医学-临床神经学

CiteScore

6.70

自引率

2.90%

发文量

161

审稿时长

4-8 weeks

期刊介绍： Acta Neurologica Scandinavica aims to publish manuscripts of a high scientific quality representing original clinical, diagnostic or experimental work in neuroscience. The journal''s scope is to act as an international forum for the dissemination of information advancing the science or practice of this subject area. Papers in English will be welcomed, especially those which bring new knowledge and observations from the application of therapies or techniques in the combating of a broad spectrum of neurological disease and neurodegenerative disorders. Relevant articles on the basic neurosciences will be published where they extend present understanding of such disorders. Priority will be given to review of topical subjects. Papers requiring rapid publication because of their significance and timeliness will be included as ''Clinical commentaries'' not exceeding two printed pages, as will ''Clinical commentaries'' of sufficient general interest. Debate within the speciality is encouraged in the form of ''Letters to the editor''. All submitted manuscripts falling within the overall scope of the journal will be assessed by suitably qualified referees.